Daewon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewon Pharmaceutical Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
Ildong Holdings Co Ltd
sales of 292.22 billion Korean Won [US$256.28 million]
of which 86%
was Pharmaceutical manufacturing and sales),
IL-Yang Pharmaceutical Company Limited
(324.57 billion Korean Won [US$284.65 million]
of which 100%
was Pharmaceutical), and
Dong Wha Pharm Company Limited
(307.15 billion Korean Won [US$269.37 million]
of which 100%
During the year ended December of 2019, sales at
Daewon Pharmaceutical Co Ltd were 317.83 billion Korean Won (US$278.73 million).
increase of 10.9%
versus 2018, when the company's sales were 286.65 billion Korean Won .
This was the fifth consecutive year of sales increases at Daewon Pharmaceutical Co Ltd
(and since 2014, sales have increased a total of 75%).
Sales of Phamaceutical saw an increase
11.2% in 2019, from
283.58 billion Korean Won to 315.31 billion Korean Won .
Not all segments of Daewon Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Hearing Aid fell 12.6% to 2.93 billion Korean Won .
(However, this segment's sales were only a very small portion of the company's overall sales).